SCHEMBL6169838

SCHEMBL6169838

COC(=O)Cc1cn(C(=O)C2CCC2)c2cc(Cl)ccc12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.47
PRPS1 P60891 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PTGDR2 Q9Y5Y4 4/20 0.38
PTGDR Q13258 1/20 0.38
PLA2G1B P04054 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
AKR1C2 P52895 2/20 0.37
AKR1C4 P17516 1/20 0.37
PTGS1 P23219 1/20 0.37
IDE P14735 1/20 0.37
MAPK8 P45983 2/20 0.37
MCHR1 Q99705 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172688 0.95 AKR1C3 (0.49) AKR1C3PRPS1ALDH1A1MAPTHPGD
SCHEMBL6169150 0.86 AKR1C3 (0.44) AKR1C3ALDH1A1PTGDR2AKR1C2AKR1C4
SCHEMBL6171169 0.81 AKR1C3 (0.46) AKR1C3ALDH1A1PTGDR2AKR1C2AKR1C4
SCHEMBL24813004 0.79 AKR1C3 (0.51) AKR1C3ALDH1A1MAPTHPGDTDP1
SCHEMBL30708130 0.79 AKR1C3 (0.51) AKR1C3ALDH1A1MAPTHPGDTDP1
SCHEMBL840601 0.75 PTGDR2 (0.45) AKR1C3PRPS1ALDH1A1MAPTHPGD
SCHEMBL7202476 0.74 CNR1 (0.40) MAPTHPGDPTGS1IDE
SCHEMBL840578 0.70 MAPK8 (0.48) ALDH1A1PTGDR2MAPK8
SCHEMBL2003238 0.69 ALDH1A1 (0.49) AKR1C3ALDH1A1MAPTHPGDTDP1
SCHEMBL28977346 0.68 AKR1C3 (0.49) AKR1C3ALDH1A1PTGDR2AKR1C2AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1284064-A 2,3-substituted indole compounds as cox-2 inhibitors PFIZER PHARMA (US) 2001-02-14 CN claimed
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
CN-1284064-A 2,3-substituted indole compounds as cox-2 inhibitors PFIZER PHARMA (US) 2001-02-14 CN disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed